{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:38:21Z","timestamp":1788777501843,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":704,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1111\/jth.15131","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:25:53Z","timestamp":1602548753000},"page":"139-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["In vivo modulation of a dominant\u2010negative variant in mouse models of von Willebrand disease type 2A"],"prefix":"10.1016","volume":"19","author":[{"given":"Matteo","family":"Campioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette","family":"Legendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Loubiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-7055","authenticated-orcid":false,"given":"Mirko","family":"Pinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-6336","authenticated-orcid":false,"given":"Olivier D.","family":"Christophe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7937-3429","authenticated-orcid":false,"given":"Peter J.","family":"Lenting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5152-9156","authenticated-orcid":false,"given":"C\u00e9cile V.","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8271-6795","authenticated-orcid":false,"given":"Caterina","family":"Casari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.15131_bb0010","doi-asserted-by":"crossref","first-page":"100572","DOI":"10.1016\/j.blre.2019.04.001","article-title":"Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor","volume":"38","author":"Peyvandi","year":"2019","journal-title":"Blood Rev"},{"key":"10.1111\/jth.15131_bb0015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Working Party on von Willebrand Disease C. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15131_bb0020","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's Disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.15131_bb0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.thromres.2017.09.025","article-title":"Von Willebrand disease mutation spectrum and associated mutation mechanisms","volume":"159","author":"de Jong","year":"2017","journal-title":"Thromb Res"},{"key":"10.1111\/jth.15131_bb0030","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","article-title":"Defective dimerization of von Willebrand factor subunits due to a Cys\u2010> Arg mutation in type IID von Willebrand disease","volume":"93","author":"Schneppenheim","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.15131_bb0035","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V98.3.674","article-title":"Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy\u2010terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease","volume":"98","author":"Enayat","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0040","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V97.7.2059","article-title":"Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease","volume":"97","author":"Schneppenheim","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0045","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0050","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1365-2141.2000.01944.x","article-title":"Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect","volume":"108","author":"Castaman","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.15131_bb0055","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood.V98.10.2973","article-title":"Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins","volume":"98","author":"Bodo","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15131_bb0065","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1182\/blood-2010-02-268920","article-title":"The dominant\u2010negative von Willebrand factor gene deletion p. P1127_C1948delinsR: molecular mechanism and modulation","volume":"116","author":"Casari","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0070","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/jth.14140","article-title":"Correction of a dominant\u2010negative von Willebrand factor multimerization defect by small interfering RNA\u2010mediated allele\u2010specific inhibition of mutant von Willebrand factor","volume":"16","author":"de Jong","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15131_bb0075","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/iub.487","article-title":"Targeted siRNA delivery to diseased microvascular endothelial cells: cellular and molecular concepts","volume":"63","author":"Kowalski","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1111\/jth.15131_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12967-017-1270-0","article-title":"RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations","volume":"15","author":"Nabzdyk","year":"2017","journal-title":"J Transl Med"},{"key":"10.1111\/jth.15131_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.addr.2016.08.004","article-title":"Functional peptides for siRNA delivery","volume":"110\u2013111","author":"Tai","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1111\/jth.15131_bb0090","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/jth.15131_bb0095","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood-2008-02-142943","article-title":"Altered thrombus formation in von Willebrand factor\u2010deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa","volume":"112","author":"Marx","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0100","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2009-11-254193","article-title":"Mutation and ADAMTS13\u2010dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B","volume":"115","author":"Rayes","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0105","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2012-09-456038","article-title":"Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein","volume":"121","author":"Legendre","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/ATVBAHA.107.159442","article-title":"Correction of bleeding symptoms in von Willebrand factor\u2010deficient mice by liver\u2010expressed von Willebrand factor mutants","volume":"28","author":"Marx","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.15131_bb0115","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2013-03-493312","article-title":"Accelerated uptake of VWF\/platelet complexes in macrophages contributes to VWD type 2B\u2010associated thrombocytopenia","volume":"122","author":"Casari","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0120","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(91)90648-I","article-title":"Induction of specific storage organelles by von Willebrand factor propolypeptide","volume":"64","author":"Wagner","year":"1991","journal-title":"Cell"},{"key":"10.1111\/jth.15131_bb0125","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1182\/blood-2012-11-465674","article-title":"Acute and severe coagulopathy in adult mice following silencing of hepatic antithrombin and protein C production","volume":"121","author":"Safdar","year":"2013","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0130","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jhep.2015.11.002","article-title":"Liver Bid suppression for treatment of fibrosis associated with non\u2010alcoholic steatohepatitis","volume":"64","author":"Eguchi","year":"2016","journal-title":"J Hepatol"},{"key":"10.1111\/jth.15131_bb0135","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1538-7836.2009.03433.x","article-title":"The active conformation of von Willebrand factor in patients with thrombotic thrombocytopenic purpura in remission","volume":"7","author":"Groot","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.15131_bb0140","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1074\/jbc.M310436200","article-title":"An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation","volume":"279","author":"Lenting","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.15131_bb0145","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood.V75.3.677.677","article-title":"A de novo and heterozygous gene deletion causing a variant of von Willebrand disease","volume":"75","author":"Bernardi","year":"1990","journal-title":"Blood"},{"key":"10.1111\/jth.15131_bb0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/hmg\/2.5.545","article-title":"In\u2010frame deletion of von Willebrand factor A domains in a dominant type of von Willebrand disease","volume":"2","author":"Bernardi","year":"1993","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15131","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.15131","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362200441X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362200441X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.15131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:30:07Z","timestamp":1761535807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362200441X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S153878362200441X"],"URL":"https:\/\/doi.org\/10.1111\/jth.15131","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo modulation of a dominant\u2010negative variant in mouse models of von Willebrand disease type 2A","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.15131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}